Products in the United States containing genetically modified organisms (GMOs) will be labeled as “bioengineered” under new food disclosure rules that took effect on Jan. 1.
President Joe Biden continues ignoring state demands for more monoclonal antibody treatments, as shortages are preventing Americans seeking the treatment from accessing them.
